Legislator Giurisprudenza & Legislazione
DE FR IT EN
Analizza in Legislator
5 B 1/12, 5 B 1/12 (5 C 6/12) Generato dall'IA

Eligibility of pharmaceutical expenses for financial assistance and validity of fixed-cap determinations

Numero d'incarto 5 B 1/12, 5 B 1/12 (5 C 6/12)
Autorità giudiziaria
Giurisdizione Germania (DE)
Data della decisione
Esito del giudizio Accolto (Allowed)
Apri la fonte ufficiale Versione Markdown leggibile dalle macchine (.md)

Sintesi Legislator

Generato dall'IA

The Federal Administrative Court (BVerwG) admitted the revisionary appeal for grounds of general legal significance and ordered a full review of the administrative court's judgment. The dispute concerns the eligibility of expenses for pharmaceuticals for state financial assistance (Beihilfe), specifically challenging whether the application of fixed amounts as a statutory cap on reimbursement was legally valid. The decisive legal issue identified is the set of requirements for the legally effective determination of such fixed caps, which the lower court's reasoning left unresolved.

Regesto Legislator

Generato dall'IA

§ 132 Abs. 2 Nr. 1 VwGO; Eligibility of pharmaceutical expenses for financial assistance and validity of fixed-cap determinations: Die Revision gegen das Urteil des Verwaltungsgerichtshofs Baden-Württemberg vom 4. August 2011 ist nach § 132 Abs. 2 Nr. 1 VwGO wegen grundsätzlicher Bedeutung der Rechtssache zuzulassen. Die Revision kann zur Klärung der Anforderungen an eine rechtswirksame Bestimmung von Festbeträgen als Obergrenze für die Beihilfefähigkeit der Aufwendungen für Arzneimittel beitragen.

Parole chiave

Generato dall'IA
aiuto finanziario spese generali presupposti legali requisito di validità motivo di revisione calcolo del reddito da valido

Disposizioni normative citate

Generato dall'IA
§ 132 Abs. 2 Nr. 1 VwGO
August 2011 ist nach § 132 Abs. 2 Nr. 1 VwGO wegen grundsätzlicher Bedeutung der Rechtssache zuzulassen.
Generato dall'IA
5 C 6/12
Federal supplementary benefit law: validity of fixed cap limits on drug reimbursement without explicit administrative regulations.
5 C 2/12
Federal medical aid eligibility for pharmaceuticals not limited by statutory health insurance fixed reference prices due to lack of legal basis
B 6 KA 75/16 B
Reimbursement of prescription costs for fictitily authorized drugs and applicability of prior committee review exception under § 106 SGB V
5 C 4/12
Federal supplementary benefits: Absence of statutory basis for capping pharmaceutical expenses at GKV fixed amounts
5 C 6/16
Validity of the statutory exclusion of non-prescription medications from federal beihilfe benefits

Ti chiedi come si applica questa sentenza alla tua fattispecie?

Analizza questa decisione insieme alla legislazione federale e cantonale, ai commentari e alla giurisprudenza successiva in Legislator AI.

Apri in Legislator →

Testo completo

Beihilfefähigkeit der Aufwendungen für Arzneimittel

[GRUENDE]

Die Revision gegen das Urteil des Verwaltungsgerichtshofs Baden-Württemberg vom 4. August 2011 ist nach § 132 Abs. 2 Nr. 1 VwGO wegen grundsätzlicher Bedeutung der Rechtssache zuzulassen. Die Revision kann zur Klärung der Anforderungen an eine rechtswirksame Bestimmung von Festbeträgen als Obergrenze für die Beihilfefähigkeit der Aufwendungen für Arzneimittel beitragen.